ID   MCF7/XBP1
AC   CVCL_EQ29
DR   cancercelllines; CVCL_EQ29
DR   GEO; GSM212608
DR   GEO; GSM212609
DR   GEO; GSM212610
DR   Wikidata; Q54904473
RX   PubMed=17660348;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 12801; XBP1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 13
//
RX   PubMed=17660348; DOI=10.1096/fj.06-7990com;
RA   Gomez B.P., Riggins R.B., Shajahan A.N., Klimach U., Wang A.-F.,
RA   Crawford A.C., Zhu Y.-L., Zwart A., Wang M.-Y., Clarke R.;
RT   "Human X-box binding protein-1 confers both estrogen independence and
RT   antiestrogen resistance in breast cancer cell lines.";
RL   FASEB J. 21:4013-4027(2007).
//